中心静脉导管相关感染:置入部位是否仍然重要?一项法国多中心队列研究
该研究基于法国REA-REZO医疗相关感染监测队列,纳入2018年1月1日至2022年12月31日期间在193个ICU内留置并拔除、且导管尖端送微生物检查的中心静脉导管。共纳入55,663根导管(颈内30,548根、股静脉14,423根、锁骨下10,692根),导管相关血流感染发生率分别为颈内0.7[0.6-0.8]、股静脉0.7[0.6-0.9]、锁骨下0.6[0.4-0.7]例/1000导管日(p=0.248),多因素泊松回归模型显示三个置入部位间无差异。作者指出发生率低且部位间相似,但因大量导管被排除,可能存在选择偏倚,不确定性仍存。
要点
- 在193个ICU的55,663根送检导管中,颈内、股静脉、锁骨下静脉置管的CRBSI发生率分别为0.7[0.6-0.8]、0.7[0.6-0.9]、0.6[0.4-0.7]例/1000导管日,p=0.248。
- 多因素泊松回归模型显示三个置入部位之间CRBSI发生率无差异。
- CRBSI病原体中凝固酶阴性葡萄球菌占27.9%、肠杆菌目占27.5%、非发酵革兰阴性杆菌占10.4%、念珠菌属占16.9%、金黄色葡萄球菌占16.9%。
- 126,997根导管中71,314根未送尖端培养,仅55,663根纳入分析,作者认为可能存在选择偏倚。
适用人群与场景
- 2018年1月1日至2022年12月31日期间在193个ICU内留置并拔除的中心静脉导管。
- 仅纳入导管尖端送微生物分析的中心静脉导管。
研究设计与关键结果
- 研究类型为基于REA-REZO医疗相关感染监测队列的多中心队列研究,共193个ICU,纳入55,663根中心静脉导管。
- 导管部位分布:颈内静脉30,548根、股静脉14,423根、锁骨下静脉10,692根。
- CRBSI发生率:颈内静脉0.7[0.6-0.8]例/1000导管日、股静脉0.7[0.6-0.9]例/1000导管日、锁骨下静脉0.6[0.4-0.7]例/1000导管日,p=0.248。
- 多因素泊松回归模型显示三个置入部位之间CRBSI发生率无差异。
- CRBSI病原体构成:凝固酶阴性葡萄球菌27.9%、肠杆菌目27.5%、非发酵革兰阴性杆菌10.4%、念珠菌属16.9%、金黄色葡萄球菌16.9%。
证据类型、等级与局限
- 证据类型:基于医疗相关感染监测队列的多中心队列研究。
- 局限:原文报告存在潜在选择偏倚,因许多中心静脉导管被排除(126,997根中71,314根未送尖端培养)。
对床旁实践的改变
- 作者认为三个置入部位(颈内、股静脉、锁骨下静脉)的CRBSI发生率相似。
- 作者指出因许多中心静脉导管被排除,可能存在选择偏倚,不确定性仍存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: We aim to evaluate the association between central venous catheter (CVC) insertion site and microbiological CVC complications in a nationwide cohort.
METHODS: This study was conducted using the healthcare-associated infection surveillance cohort "REA-REZO" involving 193 intensive care units (ICUs). All CVC inserted and removed during the same ICU stay between January 1st 2018 and December 31st 2022 were eligible but only those whose tips were sent for microbiological analysis were included. Primary objective was to describe CVC insertion sites and subsequent catheter-related bloodstream infection (CRBSI).
RESULTS: Out of 126,997 CVCs, 71,314 were not sent for tip culture, and only 55,663 CVCs were included, (30,548 in internal jugular [IJ], 14,423 in femoral and 10,692 in subclavian [SC] sites). The incidence of CRBSI was 0.7 [0.6-0.8] in the IJ site, 0.7 [0.6-0.9] in the femoral site, and 0.6 [0.4-0.7] CRBSI per 1000 CVC days in the SC site (p = 0.248). The multivariable Poisson regression model showed no differences of CRBSI incidence rates between the three insertion sites. Microorganisms observed in CRBSI were coagulase-negative Staphylococci (27.9%), Enterobacterales (27.5%), non-fermenting Gram-negative Bacilli (10.4%), Candida sp. (16.9%), and Staphylococcus aureus (16.9%).
CONCLUSION: Low CRBSI incidence rates were reported. CRBSI incidences rates were similar in the three insertion sites. Uncertainty remains due to potential selection bias since many CVCs had to be excluded.
参考来源
- Cosme V, Massart N, Reizine F, et al. Central venous catheter-related infection: does insertion site still matter? A French multicentric cohort study. Intensive Care Med. 2024. PMID: 39287649. doi:10.1007/s00134-024-07615-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。